SGTX - Sigilon Therapeutics GAAP EPS of -$0.55 revenue of $1.99M March, 14 2022 05:45 PM Sigilon Therapeutics Inc. Sigilon Therapeutics press release (NASDAQ:SGTX):Q4 GAAP EPS of -$0.55. Q4 Revenue of $1.99M (-46.9% Y/Y). For further details see: Sigilon Therapeutics GAAP EPS of -$0.55, revenue of $1.99M